These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6659996)

  • 21. New oral antidiabetic drugs. 3.
    Ambrogi V; Bloch K; Daturi S; Logemann W; Parenti MA; Tommasini R
    Arzneimittelforschung; 1972 Mar; 22(3):542-4. PubMed ID: 5067927
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
    Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness, toxicity and action of new hypoglycemic agents].
    Wójcikowski C
    Pol Tyg Lek; 1978 Oct; 33(40):1583-4. PubMed ID: 704465
    [No Abstract]   [Full Text] [Related]  

  • 24. Binding of sulfonylurea derivatives to bovine serum albumin: part II. The relationship of binding to albumin, chemical structure, and hypoglycemic activity of sulfonamide derivatives of 2-pyrazoline-1-carboxamide.
    Wójcikowski C; Brzozowski Z; Chorosiński A
    Pol J Pharmacol Pharm; 1977; 29(5):477-83. PubMed ID: 593965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New compounds and reactions of sulfonamides with amines. XVII. Synthesis of N-(4-(2-(pyrazinecarboxamido)ethyl)-benzenesulfonyl)-alkyl-2-pyrazoline-1-carboxamides].
    Gajewski F; Brzozowski Z; Kozakiewicz I
    Acta Pol Pharm; 1977; 34(1):39-44. PubMed ID: 848319
    [No Abstract]   [Full Text] [Related]  

  • 26. Biotransformation of a new hypoglycemic agent, N-(p-toluenesulfonyl)-5-methyl-2-pyrazoline-1-carbonamide (SPC-703) in humans and rats.
    Jakubowski Z; Angielski S
    Pol J Pharmacol Pharm; 1980; 32(1):37-46. PubMed ID: 7454610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and DP-IV inhibition of cyano-pyrazoline derivatives as potent anti-diabetic agents.
    Ahn JH; Kim HM; Jung SH; Kang SK; Kim KR; Rhee SD; Yang SD; Cheon HG; Kim SS
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4461-5. PubMed ID: 15357972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentially active hypoglycemic agents from N1-nicotinoyl-2-pyrazolin-5-one derivatives and their N1-(oxynicotinoyl) analogues.
    Girges MM; Hanna MA; Rasala D; Berghot M
    Arzneimittelforschung; 1992 Nov; 42(11):1350-3. PubMed ID: 1492850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Derivatives of diamino-1,3,5-triazine. I. Synthesis of some derivatives of 2-amino-4-(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine with potential hypoglycemic effect].
    Brzozowski Z; Kozakiewicz I
    Acta Pol Pharm; 1980; 37(6):601-5. PubMed ID: 7293804
    [No Abstract]   [Full Text] [Related]  

  • 30. Preparation and antidiabetic activity of new 3-methyl-5-phenylpyrazolesulfonylurea derivatives.
    Soliman R; Feid-Allah HM
    J Pharm Sci; 1981 Jun; 70(6):602-5. PubMed ID: 6788934
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of SPC-703 on blood pressure in rabbits and rats and on isolated heart of guinea pigs.
    Matuszek M; Gagało I; Hać E
    Pol J Pharmacol Pharm; 1979; 31(5):455-9. PubMed ID: 547276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivatives of 4,5,6,7-tetrahydro-7,8,8-trimethyl-3-phenylamino-4,7-methano-2H-ind azo le with hypotensive and hypoglycemic activities. II.
    Ranise A; Bondavalli F; Schenone P; Lampa E; Greco R; Scafuro M; Marmo E
    Farmaco Sci; 1984 Mar; 39(3):200-7. PubMed ID: 6714414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential antidiabetic agents. Pyrazolo(3,4-b)pyridines.
    Höhn H; Polacek I; Schulze E
    J Med Chem; 1973 Dec; 16(12):1340-6. PubMed ID: 4358224
    [No Abstract]   [Full Text] [Related]  

  • 34. [Azoles. 12. Pyrazole carbolic acid thioamides].
    Bernard M; Bober M; Krzysztofik B; Skoczna J; Stochla K; Szymczak-Meyer L; Westfal I; Wrzeciono U
    Pharmazie; 1984 Jul; 39(7):464-6. PubMed ID: 6436841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Derivatives of diamino-1,3,5-triazine. II. Synthesis of some derivative of 2-amino-4-(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine with potential hypoglycemic effect].
    Brzozowski Z; Kozakiewicz I; Pomarnacka E; Kamiński Z
    Acta Pol Pharm; 1980; 37(6):607-13. PubMed ID: 7293805
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypoglycemic compounds. Sulfanilylurea derivatives containing amino acids and dipeptides. I.
    Vicentini CB; Guarneri M; Sarto G
    Farmaco Sci; 1983 Aug; 38(8):595-602. PubMed ID: 6617854
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral therapeutic system delivering a water insoluble drug: N-(4-[2-(3-methylpyrazole-1-carbonamide)ethyl]-benzenesulfonyl)N - cyclohexylurea (SPC-5002).
    Janicki S; Jedras Z; Sawicki W
    Acta Pharm Hung; 1988 Jul; 58(4):145-51. PubMed ID: 3223284
    [No Abstract]   [Full Text] [Related]  

  • 38. [New compounds and reactions of sulfonamides with amines. XX. Synthesis of various N-(4-(2-(,4,5-trimthoxybenzamido)-ethyl) -benzenesulfonyl) 2-pyrazoline-1-carbonamides].
    Kozakiewicz I; Brzozowski Z
    Acta Pol Pharm; 1977; 34(3):275-8. PubMed ID: 906873
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis of some substituted pyrazole-3-carboxylic acids with possible hypoglycemic and antimicrobial activity.
    Mokhtar H; Soliman R
    Pharmazie; 1978 Oct; 33(10):649-51. PubMed ID: 724745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids.
    Cottineau B; Toto P; Marot C; Pipaud A; Chenault J
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2105-8. PubMed ID: 12127514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.